Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026)
Viatris (VTRS) recorded quarterly Other Non-Current Liabilities of $2.1 billion in Q1 2026, up 3.36% quarter-over-quarter from $2.0 billion in Q4 2025, and up 12.91% on a YoY basis from $1.8 billion in Q1 2025.
Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Viatris' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $2.1 billion for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 12.91% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $2.1 billion (up 12.91% YoY), while the FY2025 annual figure was $2.0 billion, up 3.9% from the prior year.
- Other Non-Current Liabilities was $2.1 billion for Q1 2026 at Viatris, up from $2.0 billion in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.1 billion in Q1 2026 to a low of $345.0 million in Q1 2024.
- Historically, Other Non-Current Liabilities has averaged $1.6 billion across 5 years, with a median of $1.8 billion in 2022.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 79.94% in 2024, then soared 434.61% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $1.8 billion in 2022, then declined by 13.64% to $1.5 billion in 2023, then grew by 27.84% to $1.9 billion in 2024, then increased by 3.9% to $2.0 billion in 2025, then increased by 3.36% to $2.1 billion in 2026.
- The last three Other Non-Current Liabilities figures came in at $2.1 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Viatris | - | - | 1.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Bn |
| Dec 31, 2025 | 2.01 Bn |
| Sep 30, 2025 | 1.82 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.84 Bn |
| Dec 31, 2024 | 1.94 Bn |
| Sep 30, 2024 | 1.87 Bn |
| Jun 30, 2024 | 345.00 Mn |
| Mar 31, 2024 | 345.00 Mn |
| Dec 31, 2023 | 1.52 Bn |
| Sep 30, 2023 | 1.65 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.72 Bn |
| Dec 31, 2022 | 1.76 Bn |
| Sep 30, 2022 | 1.75 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.88 Bn |
| Dec 31, 2021 | 1.93 Bn |
| Sep 30, 2021 | 2.05 Bn |
| Jun 30, 2021 | 2.24 Bn |